课题基金 / 基金详情

The Strong Heart Study, Phase V

The Strong Heart Study, Phase V
强心脏研究,第五阶段
批准号:
7413285
负责人:
ELISA TAN LEE
金额:
$213.02万
依托单位国家:
美国
项目类别:
财政年份:
1988
资助国家:
美国
项目状态:
已结题
起止时间:
1988-09-30 至 2010-12-31
关键词:
AccountingAcute-Phase ProteinsAddressAgeAlaska NativeAmericanAmerican IndiansAnkleAreaArizonaArteriesAtherosclerosisBiologyBlood PressureBlood VesselsBody mass indexBudgetsC-reactive proteinCandidate Disease GeneCardiacCardiovascular DiseasesCardiovascular systemCarotid Artery PlaquesCell AdhesionCell Adhesion MoleculesCerebrumCessation of lifeChromosomesChromosomes, Human, Pair 1Chromosomes, Human, Pair 11Chromosomes, Human, Pair 12Chromosomes, Human, Pair 4ChronicClinicalCohort StudiesCommunitiesConditionCoronaryDNA ResequencingDataData AnalysesDiabetes MellitusDiseaseDyslipidemiasEFRACEmployee StrikesEnd PointEpidemicEthnic groupEvaluationEventExtended FamilyFactor AnalysisFamilyFamily StudyFamily memberFemaleFollow-Up StudiesFunctional disorderFundingGenderGenesGeneticGenetic PolymorphismGenetic TranscriptionGenome ScanGenotypeGeographic LocationsGlucoseGoalsHealthHeartHeart DiseasesHeart HypertrophyHeightHeritabilityHigh PrevalenceHyperglycemiaImmune systemIn VitroIncidenceIndividualInflammationInsulinInsulin ResistanceInterleukin-6InvestigationKidney DiseasesLeadLearningLeft Ventricular HypertrophyLeft Ventricular MassLife ExpectancyLocalizedLongevityLongitudinal StudiesMannose Binding LectinMannose-Binding LectinsMapsMeasurementMeasuresMedialMedical SurveillanceMeta-AnalysisMetabolicMethodsMorbidity - disease rateNatural ImmunityNon-Insulin-Dependent Diabetes MellitusNonesterified Fatty AcidsNumbersObesityOklahomaParticipantPathway interactionsPeripheralPeroxisome ProliferatorsPhasePhenotypePlasmaPlasminogen Activator Inhibitor 1PopulationPrevalencePrevention strategyPrincipal InvestigatorPublic HealthQuantitative Trait LociRangeRateResearchResearch PersonnelRiskRisk FactorsRunningScreening procedureSignal TransductionSingle Nucleotide PolymorphismStrokeSurvivorsSyndromeTestingTherapeuticThickTimeUltrasonographyVariantVascular DiseasesWeightWorkabstractingage effectage groupbasecardiovascular disorder riskcardiovascular risk factorcohortcostcytokinedesigndiabetes mellitus geneticsdiabeticfamily geneticsfield studyfollow-upgene functiongenetic analysisgenetic linkage analysishydroxy-aluminum polymerimprovedindexinginsulin sensitivityinterestmalemembermortalitynovelpre-clinicalprogramsthrombospondin 4toll-like receptor 4traittrendyoung adult

项目摘要

项目成果

ELISA TAN LEE的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请人提供): 心血管疾病(CVD)在美洲印第安人中流行。强心研究(SHS)一直在通过在3个地理区域(亚利桑那州、达科他州和俄克拉何马州)的13个社区进行纵向队列研究和家庭遗传学研究来检查心血管疾病及其危险因素。本申请建议扩展SHS以实现以下目标:1)扩大遗传学研究,强调基因组扫描方法,但也包括对精心挑选的候选基因的调查。来自94个大家庭的3776名成员的完整基因组扫描将用于识别数量性状基因座,并通过精细作图缩小感兴趣区域。我们还将检查选定的一些候选基因,这些基因在连锁研究的基础上很难排除,但对血管疾病具有潜在的重要性。(2)继续对原队列(约2859名男性和女性幸存者,年龄60-89岁)进行死亡率和发病率监测,并启动对非队列家庭成员的年度死亡率监测和有限发病率后续行动。3)重新检查家庭成员,以便分析风险因素的变化,并估计基因对变化的影响。SHS的优势包括:1)它提供服务不足的种族群体的健康数据。2)这是美国规模最大、持续时间最长的关于糖尿病患者心血管疾病及其危险因素的纵向研究。3)心脏、颈动脉和动脉超声测量的数据将极大地提高对糖尿病血管疾病机制和心血管疾病遗传学的了解。4)这一群体包括这样一个群体,肥胖和糖尿病的流行在很小的年龄就影响了人们,使得能够分析这些疾病的遗传和环境影响,但年龄影响的混杂程度有限。SHS将为美国和世界上肥胖、糖尿病和心血管疾病流行迅速发展的这一人群和其他人群带来有价值的治疗和预防战略。这项研究与公共健康的相关性:SHS研究了美国印第安人社区的心脏和血管疾病,以试图解释最近观察到的快速增长。这项研究试图了解疾病的预测因素,并了解这种疾病在多大程度上存在于家庭中。SHS很有价值,因为它提供了关于糖尿病如何导致心脏和血管疾病的信息,这些信息将对许多现在糖尿病发病率较高的人群有用。(摘要结束)
英文摘要
DESCRIPTION (provided by applicant): There is an epidemic of cardiovascular disease (CVD) among American Indians. The Strong Heart Study (SHS) has been examining CVD and its risk factors by conducting a longitudinal cohort study and a family genetic study among 13 communities in 3 geographic areas (Arizona, the Dakotas, and Oklahoma). This application proposes to extend the SHS to pursue the following aims: 1) Expand the genetic studies that will emphasize the genome scan approach, but also include investigation of carefully selected candidate genes. The completed genome scan of 3776 members from 94 extended families will be used to identify quantitative trait loci and narrow the regions of interest by fine mapping. We also will examine a selected number of candidate genes that are difficult to exclude on the basis of linkage studies, but are of potential importance to vascular disease. 2) Continue the mortality and morbidity surveillance of the original cohort (approximately 2859 male and female survivors, ages 60 - 89 years) and to initiate annual mortality surveillance and limited morbidity follow-up of the non-cohort family members. 3) Re-examine the family members so that changes in risk factors can be analyzed and genetic effects on changes estimated. Advantages of the SHS include: 1) It provides health data on an underserved ethnic group. 2) It is the largest, longest longitudinal study in the US of CVD and its risk factors in individuals with diabetes. 3) Data from cardiac, carotid, and popliteal ultrasound measures will substantially improve understanding of mechanisms of vascular disease in diabetes and the genetics of CVD. 4) This population includes a group, in which the epidemic of obesity and diabetes has impacted people at very young ages, permitting analysis of genetic and environmental effects on these conditions with limited confounding by age effects. SHS will lead to valuable therapeutic and prevention strategies for this and other populations in the US and the world, where the epidemics of obesity, diabetes, and CVD are progressing rapidly. The relevance of this research to public health: The SHS studies diseases of the heart and blood vessels in American Indian Communities, in order to try to explain the rapid increases that have been recently observed. The study is attempting to learn about predictors of disease, and to see to what extent it runs in families. SHS is valuable because it provides information on how diabetes leads to diseases of the heart and blood vessels that will be useful in many populations who now have high rates of diabetes. (End of Abstract)
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
CVD in American Indians Study and Data Management Center and OK Field Center
CVD in American Indians Study and Data Management Center and OK Field Center
CVD in American Indians Study and Data Management Center and OK Field Center
Genetic Variations in the HPA Axis and Comorbidity of Depression and Cardiovascul
海外基金